Prevalence Of Keratoconus Among Patients With Thyroid Gland Dysfunction
NCT ID: NCT04346992
Last Updated: 2022-09-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
400 participants
OBSERVATIONAL
2020-04-12
2022-03-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Possible Role of Thyroxine in Keratoconus Development
NCT03637673
Corneal Tomographic Parameters in TGD
NCT04433936
The Effect of Thyroid Hormon Levels on the Corneal Measures
NCT04752969
AS-OCT of the Cornea in Thyroid Diseases
NCT05241626
The Effect of Early Total Thyroidectomy in the Course of Graves' Orbitopathy
NCT01056419
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
We aim to examine the prevalence of KC among patients already diagnosed by endocrinologist with TGD.
Materials and methods
Our Screening for KC will include evaluation of the demographic data and complete ophthalmological examination of the patients using:
VA Refraction K reading Slit lamp examination Pentacam Study design Epidemiological study
Inclusion citeria All patients diagnosed as thyroid gland dysfunction Control group
Exclusion criteria Uncooperative patients
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
no intervention
no intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fayoum University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Omar Said
Dr
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fayoum University
Al Fayyum, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R109
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.